Peyron J F, Verma S, de Waal Malefyt R, Sancho J, Terhorst C, Spits H
DNAX Research Institute, Human Immunology Department, Palo Alto, CA 94304-1104.
Int Immunol. 1991 Dec;3(12):1357-66. doi: 10.1093/intimm/3.12.1357.
Stimulation of the T cell antigen receptor, TCR-CD3, induces tyrosine phosphorylation of specific cellular proteins through activation of a tyrosine kinase. The possible regulatory role of the CD45 protein tyrosine phosphatase in this process was explored by studying the functional properties of cellular variants of the Jurkat T cell line which have been selected to have normal levels of the TCR-CD3 complex, but low or negative expression of CD45. These variants had less than 20% of the normal membrane tyrosine phosphatase activity. Triggering the TCR-CD3 receptor on the CD45 variants with anti-CD3 mAb induced the activation of a tyrosine kinase. Tyrosine phosphorylation of cellular substrates as well as of the CD3 zeta chain was qualitatively comparable to normal cells although the extent of stimulation was lower. No differences were observed between the variants and the normal cells in the duration of the tyrosine phosphorylation signal. The increase in intracellular calcium concentration following receptor stimulation was also less efficient, suggesting that CD45 is necessary for optimal generation of the second messengers of the activation. The CD45 deficient cells secreted highly reduced levels of lymphokines (IL-2, IL-3 or GM-CSF) after activation by anti-CD3 mAb combined with the phorbol ester TPA. This impaired lymphokines production is related to the absence of CD45 since a CD45+ revertant subclone, isolated from one CD45- clone, produced normal levels of cytokines upon activation via CD3, while CD45- subclones were unable to secrete cytokines following activation via CD3. However, upon activation with Ca2+ ionophore and PMA, all CD45- (sub)clones secreted cytokines at levels comparable to those produced by CD45+ cells. These results show that CD45 is required for cytokine production after activation via the TCR-CD3 complex.
T细胞抗原受体(TCR - CD3)的刺激通过酪氨酸激酶的激活诱导特定细胞蛋白的酪氨酸磷酸化。通过研究Jurkat T细胞系细胞变体的功能特性,探讨了CD45蛋白酪氨酸磷酸酶在此过程中可能的调节作用。这些变体被选择为具有正常水平的TCR - CD3复合物,但CD45表达低或呈阴性。这些变体的膜酪氨酸磷酸酶活性不到正常水平的20%。用抗CD3单克隆抗体触发CD45变体上的TCR - CD3受体会诱导酪氨酸激酶的激活。细胞底物以及CD3 ζ链的酪氨酸磷酸化在质量上与正常细胞相当,尽管刺激程度较低。在酪氨酸磷酸化信号的持续时间方面,变体与正常细胞之间未观察到差异。受体刺激后细胞内钙浓度的增加也效率较低,这表明CD45对于激活的第二信使的最佳产生是必需的。在用抗CD3单克隆抗体与佛波酯TPA联合激活后,CD45缺陷细胞分泌的淋巴因子(IL - 2、IL - 3或GM - CSF)水平大幅降低。这种淋巴因子产生受损与CD45的缺失有关,因为从一个CD45 - 克隆分离出的CD45 + 回复亚克隆在通过CD3激活时产生正常水平的细胞因子,而CD45 - 亚克隆在通过CD3激活后无法分泌细胞因子。然而,在用钙离子载体和PMA激活后,所有CD45 - (亚)克隆分泌细胞因子的水平与CD45 + 细胞产生的水平相当。这些结果表明,通过TCR - CD3复合物激活后产生细胞因子需要CD45。